Publications and other scientific contributions

Druggable Growth Dependencies and Tumor Evolution Analysis in Patient-Derived Organoids of Neuroendocrine Neoplasms from Multiple body sites. Dayton TL, Alcala N, Moonen L, den Hartigh L, Geurts V, Mangiante L, Lap L, Dost AFM, Beumer J, Levy S, van Leeuwaarde RS, Hackeng WM, Samsom K, Voegele C, Sexton-Oates A, Begthel H, Korving J, Hillen L, Brosens LAA, Lantuejoul S, Jaksani S, Kok NF, Hartemink KJ, Klomp HM, Rinkes IHB, Dingemans A, Valk GD, Vriens MR, Buikhuisen W, van den Berg J, Tesselaar M, Derks J, Speel EJ, Foll M, Fernández-Cuesta L, Clevers H. Cancer Cell, 2023. PMID: 38086335. Check the associated Editorial and IARC Press Release.

Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity. Mangiante L, Alcala N, Di Genova A, Sexton-Oates A, Gonzalez-Perez A, Khandekar A, Bergstrom EN, Kim J, Liu X, Giacobi C, Le Stang N, Boyault S, Cuenin C, Tabone-Eglinger S, Damiola F, Voegele C, Ardin M, Michallet M-C, Soudade L, Delhomme TM, Poret A, Brevet M, Copin M-C, Giusiano-Courcambeck S, Damotte D, Girard C, Hofman V, Hofman P, Mouroux J, Lacomme S, Mazieres J, Thomas de Montpreville V, Perrin C, Planchard G, Rousseau N, Rouquette I, Sagan C, Scherpereel A, Thivolet F, Vignaud J-M, Jean D, Gilg  Soit Ilg A, Olaso R, Meyer V, Boland A, Deleuze J-F, Altmuller J, Nuernberg P, Lantuejoul S, Ghantous A, Maussion C, Courtiol P, Hernandez-Vargas H, Caux C, Girard N, Lopez-Bigas N, Alexandrov LB, Galateau-Salle F, Foll M, Fernandez-Cuesta L. Nat Genet 2023 PMID: 36928603 – IARC Press Release 

Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids. Alcala N, Leblay N, Gabriel AAG, Mangiante L, Hervas D, Giffon T, Sertier AS, Ferrari A, Derks J, Ghantous A, Delhomme TM, Chabrier A, Cuenin C, Abedi-Ardekani B, Boland A, Olaso R, Meyer V, Altmuller J, Le Calvez-Kelm F, Durand G, Voegele C, Boyault S, Moonen L, Lemaitre N, Lorimier P, Toffart AC, Soltermann A, Clement JH, Saenger J, Field JK, Brevet M, Blanc-Fournier C, Galateau-Salle F, Le Stang N, Russell PA, Wright G, Sozzi G, Pastorino U, Lacomme S, Vignaud JM, Hofman V, Hofman P, Brustugun OT, Lund-Iversen M, Thomas de Montpreville V, Muscarella LA, Graziano P, Popper H, Stojsic J, Deleuze JF, Herceg Z, Viari A, Nuernberg P, Pelosi G, Dingemans AMC, Milione M, Roz L, Brcic L, Volante M, Papotti MG, Caux C, Sandoval J, Hernandez-Vargas H, Brambilla E, Speel EJM, Girard N, Lantuejoul S, McKay JD, Foll M, Fernandez-Cuesta L. Nat Commun. 2019 PMID: 31431620 – IARC Press Release

Identification of defined molecular subgroups based on immunohistochemical analyses and potential therapeutic vulnerabilities of pulmonary carcinoids. D.J.G. Leunissen, L. Moonen, J.H. von der Thüsen, M.A. den Bakker, L.M. Hillen, T.J.J. van Weert, A. zur Hausen, T.P.P. van den Bosch, L.M.V. Lap, R.A. Damhuis, N.L. Reynaert, Esther C. van den Broek, L. Fernandez-Cuesta, M. Foll, N. Alcala, A. Sexton Oates, A.-M.C. Dingemans, E.J.M. Speel, J.L. Derks. Journal of Thoracic Oncology, 2024. PMID: 39581377

Assessment of the current and emerging criteria for the histopathological classification of lung neuroendocrine tumours in the lungNENomics project. Mathian E, Drouet Y, Sexton-Oates, Papotti MG, Pelosi G, Vignaud J-M, Brcic L, Mansuet-Lupo A, Damiola F, Altun C, Berthet J-P, Blanc Fournier C, Brustugun OT, Centonze G, Chalabreysse L, De Montpréville VT, Di Micco CM, Fadel E, Gadot N, Graziano P, Hofman P, Hofman V, Lacomme S, Lund-Iversen M, Mangiante L, Milione M, Muscarella LA, Perrin C, Planchard G, Popper H, Rousseau N, Roz L, Sabella G, Tabone-Eglinger S, Voegele C, Volante M, Walter T, Dingemans A-M, Moonen L, Jan Speel E, Derks J, Girard N, Chen L, Alcala N, Fernandez-Cuesta L, Sylvie Lantuejoul S, Foll M. ESMO Open, 2024. PMID: 38878324.

Clinical management of typical and atypical carcinoids / neuroendocrine tumors in ENETS Centers of Excellence (CoE): Survey from the ENETS lung NET task force. Koumarianou A, Filosso PL, Bodei L, Castano JP, Fernandez-Cuesta L, Deroose CM, Foll M, Dromain C, Reed NS, Caplin M, Capdevila J, Falkerby J, Faggiano A, Frilling A, Grande E, Hicks R, Kasajima A, Kos-Kulda B, Krishna BA, Lim E, Rinke A, Singh S, Thirlwell C, Volante M, Walter T. J. Neuroendocrinol., 2024. PMID: 38754956.

Multi-omic dataset of patient-derived tumor organoids of neuroendocrine neoplasms. Alcala N, Voegele C, Mangiante L, Sexton-Oates A, Clevers H, Fernandez-Cuesta L, Dayton TL, Foll M. GigaScience, Volume 13, 2024. PMID: 38451475.

Druggable Growth Dependencies and Tumor Evolution Analysis in Patient-Derived Organoids of Neuroendocrine Neoplasms from Multiple body sites. Dayton TL, Alcala N, Moonen L, den Hartigh L, Geurts V, Mangiante L, Lap L, Dost AFM, Beumer J, Levy S, van Leeuwaarde RS, Hackeng WM, Samsom K, Voegele C, Sexton-Oates A, Begthel H, Korving J, Hillen L, Brosens LAA, Lantuejoul S, Jaksani S, Kok NF, Hartemink KJ, Klomp HM, Rinkes IHB, Dingemans A, Valk GD, Vriens MR, Buikhuisen W, van den Berg J, Tesselaar M, Derks J, Speel EJ, Foll M, Fernández-Cuesta L, Clevers H. Cancer Cell, 2023. PMID: 38086335. Check the associated Editorial and IARC Press Release.

Spotlight on small-cell lung cancer and other lung neuroendocrine neoplasms. Fernandez-Cuesta L, Sexton-Oates A, Bayat L, Foll M, Lau SCM, Leal T. ASCO Educational Book 2023 PMID: 37229617

Differential Orthopedia Homeobox expression in pulmonary carcinoids is associated with changes in DNA methylation. Moonen L, Mangiante L, Leunissen DJG, Lap LMV, Gabriel A, Hillen LM, Roemen GM, Koch A, van Engeland M, Dingemans AC, Foll M, Alcala N, Fernandez-Cuesta L, Derks JL, Speel EM. Int J Cancer. 2022 PMID: 35076935

A molecular map of lung neuroendocrine neoplasms. Gabriel AAG, Mathian E, Mangiante L, Voegele C, Cahais V, Ghantous A, McKay JD, Alcala N, Fernandez-Cuesta L, Foll M. Gigascience 2020. PMID: 33124659

Accessing and reviewing Controlled Access Data of Rare Cancers. Q&A with Matthieu Foll Gigascience Blog 2020

New molecular classification of large cell neuroendocrine carcinoma and small cell lung carcinoma with potential therapeutic impacts. Lantuejoul S, Fernandez-Cuesta L, Damiola F, Girard N, McLeer A. Transl Lung Cancer Res. 2020. PMID: 33209646

Impact clinique des études moléculaires des tumeurs neuroendocrines pulmonaires. Foll M, Fernandez-Cuesta L. Correspondances en Onco-Thoracique 2020

Molecular studies of lung neuroendocrine neoplasms uncover new concepts and entities. Fernandez-Cuesta L, Foll M. Transl Lung Cancer Res. 2019 PMID: 32038931

Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids. Alcala N, Leblay N, Gabriel AAG, Mangiante L, Hervas D, Giffon T, Sertier AS, Ferrari A, Derks J, Ghantous A, Delhomme TM, Chabrier A, Cuenin C, Abedi-Ardekani B, Boland A, Olaso R, Meyer V, Altmuller J, Le Calvez-Kelm F, Durand G, Voegele C, Boyault S, Moonen L, Lemaitre N, Lorimier P, Toffart AC, Soltermann A, Clement JH, Saenger J, Field JK, Brevet M, Blanc-Fournier C, Galateau-Salle F, Le Stang N, Russell PA, Wright G, Sozzi G, Pastorino U, Lacomme S, Vignaud JM, Hofman V, Hofman P, Brustugun OT, Lund-Iversen M, Thomas de Montpreville V, Muscarella LA, Graziano P, Popper H, Stojsic J, Deleuze JF, Herceg Z, Viari A, Nuernberg P, Pelosi G, Dingemans AMC, Milione M, Roz L, Brcic L, Volante M, Papotti MG, Caux C, Sandoval J, Hernandez-Vargas H, Brambilla E, Speel EJM, Girard N, Lantuejoul S, McKay JD, Foll M, Fernandez-Cuesta L. Nat Commun. 2019 PMID: 31431620 – IARC Press Release

A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. Rindi G, Klimstra DS, Abedi-Ardekani B, Asa SL, Bosman FT, Brambilla E, Busam KJ, de Krijger RR, Dietel M, El-Naggar AK, Fernandez-Cuesta L, Klöppel G, McCluggage WG, Moch H, Ohgaki H, Rakha EA, Reed NS, Rous BA, Sasano H, Scarpa A, Scoazec JY, Travis WD, Tallini G, Trouillas J, van Krieken JH, Cree IA. Mod Pathol. 2018 PMID: 30140036

Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors. George J, Walter V, Peifer M, Alexandrov LB, Seidel D, Leenders F, Maas L, Müller C, Dahmen I, Delhomme TM, Ardin M, Leblay N, Byrnes G, Sun R, De Reynies A, McLeer-Florin A, Bosco G, Malchers F, Menon R, Altmüller J, Becker C, Nürnberg P, Achter V, Lang U, Schneider PM, Bogus M, Soloway MG, Wilkerson MD, Cun Y, McKay JD, Moro-Sibilot D, Brambilla CG, Lantuejoul S, Lemaitre N, Soltermann A, Weder W, Tischler V, Brustugun OT, Lund-Iversen M, Helland Å, Solberg S, Ansén S, Wright G, Solomon B, Roz L, Pastorino U, Petersen I, Clement JH, Sänger J, Wolf J, Vingron M, Zander T, Perner S, Travis WD, Haas SA, Olivier M, Foll M, Büttner R, Hayes DN, Brambilla E, Fernandez-Cuesta L, Thomas RK. Nat Commun. 2018 PMID: 29535388

New insights into the molecular characteristics of pulmonary carcinoids and large cell neuroendocrine carcinomas, and the impact on their clinical management. Derks JL, Leblay N, Lantuejoul S, Dingemans AC, Speel EM, Fernandez-Cuesta L. J Thorac Oncol. 2018 Review. Erratum in: J Thorac Oncol. 2018 Aug;13(8):1229. PMID: 29454048

Molecular subtypes of pulmonary large-cell neuroendocrine carcinoma predict chemotherapy treatment outcome. Derks JL, Leblay N, Thunnissen E, van Suylen RJ, den Bakker M, Groen HJM, Smit EF, Damhuis R, van den Broek EC, Charbrier A, Foll M, McKay JD, Fernandez-Cuesta L, Speel EM, Dingemans AC; PALGA-Group. Clin Cancer Res. 2018 PMID: 29066508

Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids. Fernandez-Cuesta L, Peifer M, Lu X, Sun R, Ozretić L, Seidal D, Zander T, Leenders F, George J, Müller C, Dahmen I, Pinther B, Bosco G, Konrad K, Altmüller J, Nürnberg P, Achter V, Lang U, Schneider PM, Bogus M, Soltermann A, Brustugun OT, Helland Å, Solberg S, Lund-Iversen M, Ansén S, Stoelben E, Wright GM, Russell P, Wainer Z, Solomon B, Field JK, Hyde R, Davies MP, Heukamp LC, Petersen I, Perner S, Lovly C, Cappuzzo F, Travis WD, Wolf J, Vingron M, Brambilla E, Haas SA, Buettner R, Thomas RK. Nat Commun. 2014 PMID: 24670920

Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Peifer M, Fernández-Cuesta L, Sos ML, George J, Seidel D, Kasper LH, Plenker D, Leenders F, Sun R, Zander T, Menon R, Koker M, Dahmen I, Müller C, Di Cerbo V, Schildhaus HU, Altmüller J, Baessmann I, Becker C, de Wilde B, Vandesompele J, Böhm D, Ansén S, Gabler F, Wilkening I, Heynck S, Heuckmann JM, Lu X, Carter SL, Cibulskis K, Banerji S, Getz G, Park KS, Rauh D, Grütter C, Fischer M, Pasqualucci L, Wright G, Wainer Z, Russell P, Petersen I, Chen Y, Stoelben E, Ludwig C, Schnabel P, Hoffmann H, Muley T, Brockmann M, Engel-Riedel W, Muscarella LA, Fazio VM, Groen H, Timens W, Sietsma H, Thunnissen E, Smit E, Heideman DA, Snijders PJ, Cappuzzo F, Ligorio C, Damiani S, Field J, Solberg S, Brustugun OT, Lund-Iversen M, Sänger J, Clement JH, Soltermann A, Moch H, Weder W, Solomon B, Soria JC, Validire P, Besse B, Brambilla E, Brambilla C, Lantuejoul S, Lorimier P, Schneider PM, Hallek M, Pao W, Meyerson M, Sage J, Shendure J, Schneider R, Büttner R, Wolf J, Nürnberg P, Perner S, Heukamp LC, Brindle PK, Haas S, Thomas RK. Nat Genet. 2012 PMID: 22941188

Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity. Mangiante L, Alcala N, Di Genova A, Sexton-Oates A, Gonzalez-Perez A, Khandekar A, Bergstrom EN, Kim J, Liu X, Giacobi C, Le Stang N, Boyault S, Cuenin C, Tabone-Eglinger S, Damiola F, Voegele C, Ardin M, Michallet M-C, Soudade L, Delhomme TM, Poret A, Brevet M, Copin M-C, Giusiano-Courcambeck S, Damotte D, Girard C, Hofman V, Hofman P, Mouroux J, Lacomme S, Mazieres J, Thomas de Montpreville V, Perrin C, Planchard G, Rousseau N, Rouquette I, Sagan C, Scherpereel A, Thivolet F, Vignaud J-M, Jean D, Gilg  Soit Ilg A, Olaso R, Meyer V, Boland A, Deleuze J-F, Altmuller J, Nuernberg P, Lantuejoul S, Ghantous A, Maussion C, Courtiol P, Hernandez-Vargas H, Caux C, Girard N, Lopez-Bigas N, Alexandrov LB, Galateau-Salle F, Foll M, Fernandez-Cuesta L. Nat Genet 2023 PMID: 36928603 – IARC Press Release

Lifting the curtain on molecular differences between malignant pleural mesotheliomas. Nat Genet. 2023 PMID: 36928604 Research Briefing

A molecular phenotypic map of Malignant Pleural Mesothelioma. Di Genova A,  Mangiante L,  Sexton-Oates A,  Voegele C,  Fernandez-Cuesta L,  Alcala N,  Foll M. GigaScience 2023 PMID: 36705549

Challenges in lung and thoracic pathology: molecular advances in the classification of pleural mesotheliomas. Fernandez-Cuesta L, Mangiante L, Alcala N, Foll M. Virchows Arch. 2021 PMID: 33411030 Review

Redefining malignant pleural mesothelioma types as a continuum uncovers immune-vascular interactions. Alcala N, Mangiante L, Le-Stang N, Gustafon CE, Boyault S, Damiola F, Alcala K, Brevet M, Thivolet-Bejui F, Blanc-Fournier C, Le Rochais JP, Planchard G, Rousseau N, Damotte D, Pairon JC, Copin MC, Scherpereel A, Wasielewski E, Wicquart L, Lacomme S, Vignaud JM, Ancelin G, Girard C, Sagan C, Bonnetaud C, Hofman V, Hofman P, Mouroux J, Thomas de Montpreville V, Clermont-Taranchon E, Mazieres J, Rouquette I, Begueret H, Blay JY, Lantuejoul S, Bueno R, Caux C, Girard N, McKay JD, Foll M, Galateau-Salle F, Fernandez-Cuesta L. EBioMedicine 2019 PMID: 31648983 – EBioMedicine editorial – IARC Press Release

EURACAN/IASLC proposals for updating the histologic classification of pleural mesothelioma: towards a more multidisciplinary approach. Nicholson AG, Sauter JL, Nowak AK, Kindler HL, Gill RR, Remy-Jardin M, Armato SG, Fernandez-Cuesta L, Bueno R, Alcala N, Foll M, Pass H, Attanoos R, Baas P, Beasley MB, Brcic L, Butnor KJ, Chirieac LR, Churg A, Courtiol P, Dacic S, De Perrot M, Frauenfelder T, Gibbs A, Hirsch FR, Hiroshima K, Husain A, Klebe S, Lantuejoul S, Moreira A, Opitz I, Perol M, Roden A, Roggli V, Scherpereel A, Tirode F, Tazelaar H, Travis WD, Tsao MS, van Schil P, Vignaud JM, Weynand B, Cree I, Rusch VW, Girard N, Galateau-Salle F. J Thorac Oncol. 2019 PMID: 31546041

Highlights of the 14th international mesothelioma interest group meeting: Pathologic separation of benign from malignant mesothelial proliferations and histologic/molecular analysis of malignant mesothelioma subtypes. Churg A, Nabeshima K, Ali G, Bruno R, Fernandez-Cuesta L, Galateau-Salle F. Lung Cancer 2018 PMID: 30268487

BAP1 Is Altered by Copy Number Loss, Mutation, and/or Loss of Protein Expression in More Than 70% of Malignant Peritoneal Mesotheliomas. Leblay N, Leprêtre F, Le Stang N, Gautier-Stein A, Villeneuve L, Isaac S, Maillet D, Galateau-Sallé F, Villenet C, Sebda S, Goracci A, Byrnes G, McKay JD, Figeac M, Glehen O, Gilly FN, Foll M, Fernandez-Cuesta L, Brevet M. J Thorac Oncol. 2017 PMID: 28034829

Assessment of the current and emerging criteria for the histopathological classification of lung neuroendocrine tumours in the lungNENomics project. Mathian E, Drouet Y, Sexton-Oates, Papotti MG, Pelosi G, Vignaud J-M, Brcic L, Mansuet-Lupo A, Damiola F, Altun C, Berthet J-P, Blanc Fournier C, Brustugun OT, Centonze G, Chalabreysse L, De Montpréville VT, Di Micco CM, Fadel E, Gadot N, Graziano P, Hofman P, Hofman V, Lacomme S, Lund-Iversen M, Mangiante L, Milione M, Muscarella LA, Perrin C, Planchard G, Popper H, Rousseau N, Roz L, Sabella G, Tabone-Eglinger S, Voegele C, Volante M, Walter T, Dingemans A-M, Moonen L, Jan Speel E, Derks J, Girard N, Chen L, Alcala N, Fernandez-Cuesta L, Sylvie Lantuejoul S, Foll M. ESMO Open. 2024 PMID: 38878324

HaloAE: A Local Transformer Auto-Encoder for Anomaly Detection and Localization Based on HaloNet. E Mathian, H Liu, L Fernandez-Cuesta, D Samaras, M Foll, L Chen. Proceedings of the 18th International Joint Conference on Computer Vision, Imaging and Computer Graphics Theory and Applications (VISIGRAPP 2023) – Volume 5: VISAPP; ISBN 978-989-758-634-7; ISSN 2184-4321, SciTePress, pages 325-337. DOI: 10.5220/0011865900003417

Druggable Growth Dependencies and Tumor Evolution Analysis in Patient-Derived Organoids of Neuroendocrine Neoplasms from Multiple body sites. Dayton TL, Alcala N, Moonen L, den Hartigh L, Geurts V, Mangiante L, Lap L, Dost AFM, Beumer J, Levy S, van Leeuwaarde RS, Hackeng WM, Samsom K, Voegele C, Sexton-Oates A, Begthel H, Korving J, Hillen L, Brosens LAA, Lantuejoul S, Jaksani S, Kok NF, Hartemink KJ, Klomp HM, Rinkes IHB, Dingemans A, Valk GD, Vriens MR, Buikhuisen W, van den Berg J, Tesselaar M, Derks J, Speel EJ, Foll M, Fernández-Cuesta L, Clevers H.  Cancer Cell, 2023. Check the associated Editorial and IARC Press Release.

Mathematical constraints on FST: multiallelic markers in arbitrarily many populations. Alcala N and Rosenberg NA. Philosophical Transactions of the Royal Society series B. 2022. PMID: 35430885

FSTruct: An FST‐based tool for measuring ancestry variation in inference of population structure. Morrison ML, Alcala N, and Rosenberg NA. Molecular Ecology Resources. 2022. PMID: 35596736 

• TERT expression defines clinical outcome in pulmonary carcinoids. Werr L, Bartenhagen C, Rosswog C, Cartolano M, Voegele C, Sexton-Oates A, Di Genova A, Ernst A, Kahlert Y, Hemstedt N, Lupo AM, Pelosi G, Absenger G, Altmüller J, Berthet JP, Bibeau F, Blanc Fourner C, Boland A, Bonnetaud C, Brcic L, Brevet M, Brustugun OT, Centonze G, Chalabreysse L, Cohen C, Deleuze JF, Derks JL, Di Micco CM, Dingemans AMC, Fadel E, Graziano P, Hofman P, Hofman V, Lacomme S, Lund-Iversen M, Metovic J, Milione M, Moonen L, Muscarella LA, Nürnberg P, Olaso R, Meyer V, Papotti M, Perrin C, Planchard G, Popper H, Rousseau N, Roz L, Sabella G, SparaneoA, Speel EJM, Thivolet-Béjui F, Thomas de Montpréville V, Vignaud JM, Volante M, Wright GM, Damiola F, Tabone-Eglinger S, Girard N, George J, Bosco G, Quaas A, Tang LH, Robzyk K, Kadota K, Roh MS, Fanaroff RE, Falcon CJ, Büttner R, Lantuejoul S, Rekhtman N, Rudin C, Travis WD, Alcala N, Fernandez-Cuesta L, Foll M, Peifer M, Thomas RK, Fischer, M. JCO. 2024.

  Altered splicing machinery in lung carcinoids unveils NOVA1, PRPF8 and SRSF10 as novel candidates to understand tumor biology and expand biomarker discovery. Blázquez-Encinas R, García-Vioque V, Caro-Cuenca T, Moreno-Montilla MT, Mangili F, Alors-Pérez E, Ventura S, Herrera-Martínez AD, Moreno-Casado P, Calzado MA, Salvatierra A, Gálvez-Moreno MA, Fernandez-Cuesta L, Foll M, Luque RM, Alcala N, Pedraza-Arevalo S, Ibáñez-Costa A, Castaño JP. J Transl Med. 2023.

  Detection of acquired TERT amplification in addition to predisposing p53 and Rb pathways alterations in EGFR-mutant lung adenocarcinomas transformed into small-cell lung cancers. Mc Leer A, Foll M, Brevet M, Antoine M, Novello S, Mondet J, Cadranel J, Girard N, Giaj Levra M, Demontrond P, Audigier-Valette C, Letouzé E, Lantuéjoul S, Fernandez-Cuesta L, Moro-Sibilot D. Lung Cancer. 2022. PMID: 35183375

  Comprehensive molecular and pathological evaluation of transitional mesothelioma assisted by deep learning approach: a multi-institutional study of the International Mesothelioma Panel from MESOPATH Référence Center. Galateau Salle F, Le Stang N, Tirode F, Courtiol P, Nicholson AG, Tsao MS, Tazelaar HD, Churg A, Dacic S, Roggli V, Pissaloux D, Maussion C, Moarii M, Beasley MB, Begueret H, Chapel DB, Copin MC, Gibbs AR, Klebe S, Lantuejoul S, Nabeshima K, Vignaud JM, Attanoos R, Brcic L, Capron F, Chirieac LR, Damiola F, Sequeiros R, Cazes A, Damotte D, Foulet A, Giusiano-Courcambeck S, Hiroshima K, Hofman V, Husain AN, Kerr K, Marchevsky A, Paindavoine S, Picquenot JM, Rouquette I, Sagan C, Sauter J, Thivolet F, Brevet M, Rouvier P, Travis WD, Planchard G, Weynand B, Clozel T, Wainrib G, Fernandez-Cuesta L, Pairon JC, Rusch V, Girard N. 
J Thorac Oncol. 2020. PMID: 32165206

Since 2020, Lynnette Fernandez-Cuesta and Matthieu Foll are members of the European NEuroendocrine Tumors society (ENETS) – lung NET task force.

Lynnette Fernandez-Cuesta contributed as expert co-author to the Neuroendocrine Tumors chapter of the WHO Classification of Thoracic Tumors, 5th Ed.

Members of the Computational Cancer Genomics Team at IARC have participated as invited speaker, invited discussant, or been selected for oral presentations in the following international renown conferences:

•     – 2024 NETRF Research Symposium
•     – 2024 21st Annual ENETS Conference
•     – 2023 EMBL Cancer Genomics Conference
•     – 2023 NETRF Research Symposium
•     – 2023 IASLC World Conference on Lung Cancer
•     – 2023 ASCO Annual Meeting
•     – 2023 European Congress of Endocrinology
•     – 2023 20th Annual ENETS Conference
•     – ESMO Sarcoma and Rare Cancers Congress 2023
•     – 12th European Meeting on Molecular Diagnostics
•     – 2022 IASLC World Conference on Lung Cancer
•     – 1st World NET Forum 2022 – Annual ENETS Conference
•     – 2021 18th Annual ENETS Conference
•     – 2020 NETRF Virtual Research Symposium
•     – 2019 Gilles Thomas’ Symposium
•     – 2019 31st European Congress of Pathology
•     – XV International Symposium GETNE 2019
•     – 2019 IASLC World Conference on Lung Cancer
•     – 2018 16th Annual ENETS Conference
•     – 2018 11th Joint Meeting of the British Division of the IAP and the Pathological Society, together with the NVvP, The Dutch Pathological Society

Since 2023, Lynnette Fernandez-Cuesta is member of IASLC Mesothelioma Committee.

Since 2016, Lynnette Fernandez-Cuesta and Matthieu Foll are members of the French MESOBANK Scientific Council

Members of the Rare Cancers Genomics Team at IARC have participated as invited speaker, invited discussant, or been selected for oral presentations in the following international renown conferences:

•     – ESMO Sarcoma and Rare Cancers Congress 2024
•     – 2023 EMBL Cancer Genomics Conference
•     – 2023 VarICOSI ISMB/ECCB
•     – 2023 16th International Conference of the International Mesothelioma Interest Group
•     – 2022 IASLC World Conference on Lung Cancer
•     – 2021 Virtual 15th International Conference of the International Mesothelioma Interest Group
•     – 2021 Virtual IASLC 2020 IASLC World Conference on Lung Cancer
•     – 2020 Virtual 32nd Congress of the European Society of Pathology and XXXIII International Congress of the International Academy of Pathology
•     – 2019 4th International Cancer Symposium of the Cancer Research Center of Lyons
•     – 2019 IASLC World Conference on Lung Cancer
•     – 2018 14th International Conference of the International Mesothelioma Interest Group

Members of the Computational Cancer Genomics Team at IARC have participated as invited speaker, invited discussant, or been selected for oral presentations in the following international renown conferences:

• – 18th International Conference on Computer Vision Theory and Applications VISAPP

Members of the Computational Cancer Genomics Team at IARC have participated as invited speaker, invited discussant, or been selected for oral presentations in the following conferences or courses:

• – Ecology and evolution of rare thoracic cancers. Seminar from the Stanford Center for Computational, Evolutionary and Human Genomics, September 28th 2022. (Link to video)
• – The mathematics of population structure. PhD course from the Stanford biology graduate program. February 2022.